SecBot SecBot

PDEX

PRO DEX INC
Nasdaq· Surgical & Medical Instruments & Apparatus· CIK 0000788920 Healthcare & Medical Devices
$61.49 −0.74 (−1.18%)
Oct 26 4:00 PM ET · prev $62.22
Market cap
$201.7M
Micro cap
Consensus
Buy
86% Buy or better · 7 analysts
Median target
$74.00
+20% · range $74.00–74.00
Next earnings
Oct 29
in 3 days · EPS est. $0.67
1 year
+113.0%
from $28.87 · Oct 27
30 days
−14.2%
from $71.62
52-week range
$28.71–73.41
−16% from high · low Oct 28
Avg volume 20D
41.8K
shares / day
Short interest
199.4K
≈6.2% of shares · −5.0%
Days to cover
2.9
at average volume
Insider net
−$2.0M
0 buyers · 3 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read MIXED 5 reports · 90 days
Balance 0 bearish · 0 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 3/5 ·Next Earnings date, Oct 29, 2026
Strongest NEUTRAL Pro-Dex, Inc. filed definitive additional proxy soliciting materials (DEFA14A) on October 6, 2026, in…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • S Mar 16 1 insider sell $47.1K at $47.24
  • S May 21 to May 22 2 days of insider sells: $626.2K by 1 insider, avg $62.62
  • S Sep 9 to Sep 11 2 days of insider sells: $1.4M by 2 insiders, avg $60.61

Signal stack

Where each data set points today.

  • InsidersBEARISH

    3 insiders sold $2.0M.

  • InstitutionsMIXED

    Q2 2026: 6 added (0 new), 7 trimmed or exited.

  • AnalystsBULLISH

    6 of 7 rate it Buy or better. Every target is above the price.

  • EstimatesFLAT

    Current-quarter EPS estimate $0.660 → $0.670 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −5.0% to 199.4K shares. 2.9 days to cover, ≈6.2% of shares.

  • TrendDOWNTREND

    6% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCTRIM82,283$4.8M
GOLDMAN SACHS GROUP INCADD18,711$1.1M
NORTHERN TRUST CORPTRIM15,615$914.3K
Nuveen, LLCADD9,247$541.4K
MORGAN STANLEYTRIM8,664$507.3K
UBS Group AGTRIM4,632$271.2K
WELLS FARGO & COMPANY/MNDOUBLED1,891$110.7K
NEW YORK STATE COMMON RETIREMENT FUNDTRIM1,090$63.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

7 analysts
Buy 86% rate it Buy or better
Strong Buy2Buy4Hold1Sell0Strong Sell0
12-month targets · 1 analysts

Price is below the lowest target. Median implies +20%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 11, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy
May 12, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$2.0M
sold · 3 insiders
DateInsiderTypeValue
Sep 11, 2026
Van Kirk Richard Lee Jr
Chief Executive Officer
SELL$17.1K
Sep 11, 2026
Van Kirk Richard Lee Jr
Chief Executive Officer
SELL$28.3K
Sep 9, 2026
Charlton Alisha
Chief Financial Officer
SELL$91.6K
Sep 9, 2026
Charlton Alisha
Chief Financial Officer
SELL$49.4K
Sep 9, 2026
Van Kirk Richard Lee Jr
Chief Executive Officer
SELL$127.3K
Sep 9, 2026
Van Kirk Richard Lee Jr
Chief Executive Officer
SELL$161.0K
Sep 9, 2026
Van Kirk Richard Lee Jr
Chief Executive Officer
SELL$259.5K
Sep 9, 2026
Van Kirk Richard Lee Jr
Chief Executive Officer
SELL$71.6K

Earnings setup

Estimates
Oct 29
reports in 3 days
$0.67
EPS estimate, this quarter
+2%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.67$0.67–$0.67+1.5%$20.4M
Next Q$0.72$0.72–$0.72+4.3%$20.5M
Current FY$3.09$3.09–$3.09+11.2%$82.7M
Next FY$3.36$3.36–$3.36—$86.8M

Short side

FINRA· Sep 30, 2026
199,385
shares short
-5.0%
vs prior settlement
2.9
days to cover
≈6.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 6, 2026 SEC
Pro-Dex, Inc. filed definitive additional proxy soliciting materials (DEFA14A) on October 6, 2026, in connection with…
DEFA14A — Impact 5/10
Oct 6, 2026 SEC
Pro-Dex filed its definitive proxy statement for the 2026 annual meeting, seeking election of seven director nominees…
DEF 14A — Impact 4/10
Sep 14, 2026 SEC
CEO and CFO of Pro Dex Inc (PDEX) sold a combined $120K in open-market sales over a 7-day window, with CEO Van Kirk…
CLUSTER — Impact 2/10
Sep 11, 2026 Insider
Van Kirk Richard Lee Jr sold 290 shares
Chief Executive Officer @ $58.94 ($17.1K)
Sep 11, 2026 Insider
Van Kirk Richard Lee Jr sold 475 shares
Chief Executive Officer @ $59.62 ($28.3K)
Sep 9, 2026 Insider
Charlton Alisha sold 1,500 shares
Chief Financial Officer @ $61.05 ($91.6K)
Sep 2, 2026 Earnings calendar
PDEX Q4 2026 Earnings Scheduled — 2026-09-02
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — TRIM
82,283 shares ($4.8M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Oct 29, 2026
Earnings date
PDEX Q1 2027 Earnings Scheduled — 2026-10-29
Recent
Sep 2, 2026
Earnings date
PDEX Q4 2026 Earnings Scheduled — 2026-09-02
Aug 20, 2026
Earnings date
PDEX Q4 2026 Earnings Scheduled — 2026-08-20
Apr 30, 2026
Earnings date
PDEX Q3 2026 Earnings Scheduled — 2026-04-30
Apr 29, 2026
Earnings date
PDEX Q3 2026 Earnings Scheduled — 2026-04-29

SecBot reports

7 filings · 0 bullish · 0 bearish · 1 mixed · 6 neutral
All PDEX filing & press-release reports (7)